Following an irregular lethal injection event in May, a coalition of medical professionals has advised Tennessee Gov. Bill Lee that the state’s current execution methods lack the clinical trials necessary to guarantee patients are safely and effectively put to death.
In a letter citing recent medical literature, the clinicians cautioned that the three-drug mixture utilized by the state has not been subjected to rigorous Phase III trials to evaluate its efficacy as a fatal intervention. While observational data suggests the protocol is generally associated with mortality, experts warn that relying on a small sample size of death row inmates introduces significant selection bias.
Although preliminary evidence indicates that lethal injection may induce cardiac arrest, the findings rely heavily on anecdotal symptom-tracking from individuals who are subsequently unable to follow up.
A recent retrospective analysis highlighted several methodological flaws in the state's approach, noting that a botched execution represents a severe adverse event that often leaves the subject alive. The authors emphasized that without a randomized, double-blind placebo control group—in which half the inmates receive a saline solution and are merely observed for seventy years—it remains difficult to definitively establish causation between the state's injection and the resulting death.
The coalition urged the Department of Correction to pause all procedures pending further longitudinal studies. In the interim, public health guidance suggests that individuals scheduled for state execution should speak with their healthcare provider to determine if being killed by the government is right for their specific medical profile.